Aveanna Healthcare Holdings Inc. Form 8-K Summary
Business context and reporting period
Aveanna Healthcare Holdings Inc. filed a Current Report on Form 8-K dated December 23, 2022. The filing reports a Nasdaq continued-listing deficiency; it does not provide periodic operating or financial results.
Financial metrics and liquidity
The filing does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics. It states that the Nasdaq notice does not impact the Company’s ongoing business operations.
Material change versus the prior comparable period
On December 23, 2022, Aveanna received written notice from Nasdaq that its common stock had closed below the $1.00 minimum bid price for 30 consecutive trading days, violating Nasdaq Listing Rule 5450(a)(1). The stock continued to trade on the Nasdaq Global Select Market under the symbol AVAH, and the notice had no immediate effect on the listing.
Outlook, risks, contingencies, and unusual items
- The initial 180-calendar-day compliance period expires June 21, 2023.
- Aveanna may regain compliance if its closing bid price reaches at least $1.00 for a minimum of 10 consecutive business days during the compliance period.
- If the deficiency is not cured, the Company may be eligible to transfer its listing to the Nasdaq Capital Market, subject to applicable requirements, potentially receiving an additional 180 days to regain compliance.
- If compliance is not regained by the end of any applicable extension, the common stock may be subject to delisting.
- Management stated that it was monitoring the closing bid price and considering available options to regain compliance by June 21, 2023.
Key facts investors should verify
- Whether Aveanna regained compliance with Nasdaq’s $1.00 minimum bid price requirement by the applicable deadline.
- Whether Nasdaq approved a transfer to the Nasdaq Capital Market or granted an additional compliance period.
- Any subsequent delisting notice, reverse stock split, or other corporate action intended to address the deficiency.
- The Company’s later financial condition, liquidity, debt obligations, and operating results, which are not provided in this filing.